The professor of clinical medicine, director, Multiple Myeloma and Amyloidosis Program, New York-Presbyterian Hospital, discussed utility of cellular therapies in multiple myeloma.
Suzanne Lentzsch, MD
Advertisement
Articles by Suzanne Lentzsch, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
2
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
3
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
4
Guess the Therapy Answer October 16, 2025
5
